92 results
Page 2 of 5
8-K
EX-99.1
wbwfowwyzxk1qt1r
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
llp tjkqxa1lu0jt1w
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
fz27j615m 53ji222
21 Apr 22
Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company’s Independent Registered Public Accounting Firm
7:34am
8-K
6b38cke1 d0cuzf
1 Apr 22
Departure of Directors or Certain Officers
4:32pm
8-K
EX-99.1
mnvau8114j9
15 Mar 22
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
8:31am
8-K
EX-99.1
up9ah vy9dja9ic
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.1
f1vxri1
3 Dec 21
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
7:45am
8-K
EX-99.1
ok8qx93m5i
22 Nov 21
Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
7:40am
8-K
EX-99.3
2cwsupomxoo
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.1
2c0bl2n auxaf
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.2
iqde2i8lqo
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.1
6yhwkjufdftx
20 Oct 21
ZL-1102, Zai Lab’s Internally Developed Novel Human
4:06pm
8-K
EX-99.1
x3qmv10fe3dlpei8t
19 Oct 21
Zai Lab and Entasis Therapeutics Announce Positive
9:21am
8-K
EX-99.1
rxtnnl
18 Oct 21
Zai Lab Appoints Scott Morrison
7:38am